|
|
||||||||
1 Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA 50011-1250, USA
2 Department of Biomedical Sciences and Pathobiology, Center for Molecular Medicine and Infectious Diseases, College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061-0342, USA
Correspondence
T. Opriessnig
tanjaopr{at}iastate.edu
There are marked differences in the clinical expression of diseases associated with porcine circovirus type 2 (PCV2) in the field. The objective of this study was to compare the sequences and pathogenicity of PCV2 isolates from field cases with and without PCV2-associated lesions. Forty-two specific-pathogen-free (SPF) pigs were assigned randomly to three groups of 14 pigs each. At 7 weeks of age, group 1 pigs were mock-inoculated with saline, group 2 pigs were inoculated with PCV2-4838 (isolated from a pig with no evidence of PCV2-associated lymphoid lesions) and group 3 pigs were inoculated with PCV2-40895 (isolated from a pig with PCV2-associated lymphoid lesions and disease). The PCV2-4838 and PCV2-40895 isolates shared approximately 98.9 % nucleotide sequence identity across the entire genome. A total of nine amino acid changes in ORF2 and two amino acid changes in ORF1 were identified between the two isolates. PCV2-4838-inoculated pigs had significantly more genomic copy numbers of PCV2 in their sera at 7 days post-inoculation (p.i.) (P<0.0001) and significantly fewer genomic copy numbers at 14, 21 and 28 days p.i. (P<0.05) compared with pigs inoculated with the PCV2-40895 isolate. Microscopic lesions in lymphoid tissues were significantly less severe (P<0.05) and the amount of PCV2 antigen associated with these lesions was significantly lower (P<0.05) in pigs inoculated with PCV2-4838. The results of this study suggest that PCV2 isolates from the USA differ in virulence in an SPF pig model.
The GenBank/EMBL/DDBJ accession number for the sequence of PCV2 isolate 4838 determined in this work is DQ397521.
This article has been cited by other articles:
![]() |
C. Firth, M. A. Charleston, S. Duffy, B. Shapiro, and E. C. Holmes Insights into the Evolutionary History of an Emerging Livestock Pathogen: Porcine Circovirus 2 J. Virol., December 15, 2009; 83(24): 12813 - 12821. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Baker, D. M. Madson, A. R. Patterson, and T. Opriessnig Evaluation of the safety of four porcine circovirus type 2 tissue homogenate vaccines in a pig bioassay Vet Rec., August 29, 2009; 165(9): 262 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Madson, A. R. Patterson, S. Ramamoorthy, N. Pal, X. J. Meng, and T. Opriessnig Reproductive Failure Experimentally Induced in Sows via Artificial Insemination with Semen Spiked with Porcine Circovirus Type 2 Vet. Pathol., July 1, 2009; 46(4): 707 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Madson, S. Ramamoorthy, C. Kuster, N. Pal, X.-J. Meng, P. G. Halbur, and T. Opriessnig Characterization of shedding patterns of Porcine circovirus types 2a and 2b in experimentally inoculated mature boars J Vet Diagn Invest, November 1, 2008; 20(6): 725 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Opriessnig, S. Ramamoorthy, D. M. Madson, A. R. Patterson, N. Pal, S. Carman, X. J. Meng, and P. G. Halbur Differences in virulence among porcine circovirus type 2 isolates are unrelated to cluster type 2a or 2b and prior infection provides heterologous protection J. Gen. Virol., October 1, 2008; 89(10): 2482 - 2491. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Lefebvre, S. Costers, J. Van Doorsselaere, G. Misinzo, P. L. Delputte, and H. J. Nauwynck Antigenic differences among porcine circovirus type 2 strains, as demonstrated by the use of monoclonal antibodies J. Gen. Virol., January 1, 2008; 89(1): 177 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Opriessnig, X.-J. Meng, and P. G. Halbur Porcine Circovirus Type 2 associated disease: Update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies J Vet Diagn Invest, November 1, 2007; 19(6): 591 - 615. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |